Zdrowie i gospodarka · 06/01/2020

FDA Renews Patient Engagement Advisory Committee for 2 Years

The FDA has renewed the Patient Engagement Advisory Committee for an additional 2 years, with the new charter set to expire on October 6, 2021, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.